Clinical Trials Logo
  1. Home
  2. Small for Gestational Age
  3. NCT00519844

Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction

Small for Gestational Age Clinical Trial

Official title:
Assessment of Satisfaction With Growth Hormone Treatment in Children Born Small for Gestational Age: Benefits of Galenic Form of the Product

Clinical Trial Summary

This trial is conducted in Europe. The aim of this trial is to assess satisfaction with growth hormone treatment in children of both sexes born small for gestational age and who are receiving growth hormone treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00519844
Study type Interventional
Source Novo Nordisk A/S
Contact
Status Completed
Phase Phase 4
Start date July 2005
Completion date January 2006
View Details
See also
  Status Clinical Trial Phase
Completed NCT02218931 - ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes N/A
Recruiting NCT03662178 - Investigating the Structured Use of Ultrasound Scanning for Fetal Growth
Completed NCT01697644 - Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation Phase 4
Completed NCT01110928 - Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing
Not yet recruiting NCT02931591 - Effect of Insulin Sensitization on IGF-1 Response to Growth Hormone in SGA Children N/A
Completed NCT02280031 - Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. Phase 2
Completed NCT01245374 - Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents Phase 4
Completed NCT00184756 - Efficacy on Height in SGA Children Treated With Growth Hormone Phase 3
Completed NCT01578135 - French National Registry of Children Born Small for Gestational Age Treated With Somatropin
Recruiting NCT05603936 - Adaption and Testing of the Quality of Life in Short Stature Youth (QoLISSY) Questionnaire for Parents With Children From 0-4
Completed NCT00925925 - Epigenetic Markers of B-Cell Function in Low Birth Weight Infants N/A
Completed NCT00738205 - Evaluation of Convenience and Compliance of the Easypod™ Electronic Self-injector N/A
Completed NCT00557336 - Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age Phase 3
Completed NCT00371657 - Maternal Obesity and Small for Gestational Age Infants N/A
Completed NCT00184717 - Growth Hormone Treatment in Children Born Small for Gestational Age (SGA) Phase 3
Recruiting NCT01604395 - Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Terminated NCT00597480 - Study of Growth-promoting and Metabolic Effects of Growth Hormone (rhGH) Phase 4
Completed NCT01543867 - Safety and Efficacy of Long-term Somatropin Treatment in Children N/A
Recruiting NCT02964793 - Effects of Serial Plotting on Fundal Height Charts on Identification and Outcomes of Small for Gestational Age Infants N/A
Recruiting NCT04798690 - Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short Stature